Divalproex Sodium Tablet, Delayed Release
Product Images NDC 68001-473
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68001-473). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 02)
Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 03)
Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 04)
Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 05)
Dival 500mg 100ct Rev 07/2025 (Divalproex Sodium Dr Tablets Usp 500mg 100ct)
Dival 250mg 100ct Rev 07/2025 (Divalproex Sodium Dr Tablets Usp 250mg 100ct)
Dival 125mg 100ct Rev 07/2025 (Divalproex Sodium Dr Tablets Usp 125mg 100ct)
Divalproex Dr 125mg (Divalproex Dr Tablets 125mg 100s Label Rev 09 2023)
Divalproex Dr Tabs 250mg (Divalproex Dr Tablets 250mg 100s Label Rev 09 2023)
Divalproex Dr Tabs 500mg (Divalproex Dr Tablets 500mg 100s Label Rev 09 2023)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.